Nav: Home

Wyss Institute's Donald Ingber elected to American Academy of Arts & Sciences

April 21, 2016

(BOSTON) - Wyss Institute Founding Director and Core Faculty member Donald E. Ingber, M.D., Ph.D. has been elected to Fellow of the American Academy of Arts and Sciences, one of the nation's oldest and most prestigious honor societies and a leading center for independent policy research.

Along with 175 other new fellows and 37 Foreign Honorary Members, he joins a group of some of the world's most accomplished scholars, scientists, engineers, writers, and artists, as well as civic, business, and philanthropic leaders. The Academy convenes its leaders from the academic, business, and government sectors to provide policy advice relating to challenges facing the nation and the world.

"It is a profound honor and privilege to be elected as member of this esteemed Academy that spans the arts and sciences, as crossing these diverse fields has been a passion of my own for my entire career. I look forward to collaborating with the other Academy members to help confront pressing issues facing our world, and to develop proposals for potential solutions," said Ingber, who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.

Ingber is a pioneer in the field of biologically inspired engineering and has made lasting contributions to a broad range of scientific disciplines ranging from mechanobiology and nanobiotechnology to tumor angiogenesis, tissue engineering and translational medicine. In addition to directing the Wyss Institute, he leads its Biomimetic Microsystems Platform that develops human 'Organs-on-Chips' and microengineering-enabled therapeutics and drug delivery systems. He is also a senior member of the Vascular Biology Program at Boston Children's Hospital, where his team focuses on angiogenesis and cancer research.

Ingber, whose earliest scientific work led to the discovery that tensegrity architecture is a fundamental design principle that controls how biological systems are structured, helped to found the Wyss Institute for Biologically Inspired Engineering in 2009 with the mission to draw inspiration from the way Nature builds to develop innovative bioinspired technologies that improve human health and the environment. Core to the Wyss Institute's culture is the goal of translating these technologies out of the laboratory and into the real world, which is accomplished through the Wyss' unique environment that fosters deep, cross-institutional collaboration between scientists, entrepreneurs and industrial partners.

Ingber himself has authored more than 400 publications, is an inventor on more than 130 patents, and has launched four biotechnology startups.

In recent years, some of Ingber's most notable work includes the invention of "human organs on chips" microfluidic devices, which have the potential to deliver transformative change to pharmaceutical development and human healthcare by replacing animal testing, and a dialysis-like blood cleansing device for sepsis therapy. Boston-based startup company Emulate, Inc., spun out of the Wyss Institute in 2014 to commercialize the human organs on chips, and Cambridge-based Opsonix, Inc., was founded in 2015 to commercialize the sepsis therapeutic technology.

Founded in 1780, the Academy has elected leading thinkers and doers from each generation, including Thomas Jefferson and Benjamin Franklin in the eighteenth century, Daniel Webster and Ralph Waldo Emerson in the nineteenth, and Margaret Meade and Jonas Salk in the twentieth. Ingber and the other new members of the Academy were nominated and elected by current members, bringing the academy's ranks to more than 4,600 fellows and 600 Foreign Honorary Members, including more than 250 Nobel laureates and Pulitzer Prize winners.

The new class will be inducted at a ceremony on October 8, 2016, at the Academy's headquarters in Cambridge, Massachusetts.
-end-
PRESS CONTACT

Wyss Institute for Biologically Inspired Engineering at Harvard University
Kat J. McAlpine, katherine.mcalpine@wyss.harvard.edu, +1 617-432-8266

MULTIMEDIA CONTACT

Wyss Institute for Biologically Inspired Engineering at Harvard University
Seth Kroll, seth.kroll@wyss.harvard.edu, +1 617-432-7758

The Wyss Institute for Biologically Inspired Engineering at Harvard University (http://wyss.harvard.edu) uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing that are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and formation of new startups. The Wyss Institute creates transformative technological breakthroughs by engaging in high risk research, and crosses disciplinary and institutional barriers, working as an alliance that includes Harvard's Schools of Medicine, Engineering, Arts & Sciences and Design, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, Charité - Universitätsmedizin Berlin, University of Zurich and Massachusetts Institute of Technology

Wyss Institute for Biologically Inspired Engineering at Harvard

Related Engineering Articles:

Engineering the meniscus
Damage to the meniscus is common, but there remains an unmet need for improved restorative therapies that can overcome poor healing in the avascular regions.
Artificially engineering the intestine
Short bowel syndrome is a debilitating condition with few treatment options, and these treatments have limited efficacy.
Reverse engineering the fireworks of life
An interdisciplinary team of Princeton researchers has successfully reverse engineered the components and sequence of events that lead to microtubule branching.
New method for engineering metabolic pathways
Two approaches provide a faster way to create enzymes and analyze their reactions, leading to the design of more complex molecules.
Engineering for high-speed devices
A research team from the University of Delaware has developed cutting-edge technology for photonics devices that could enable faster communications between phones and computers.
Breakthrough in blood vessel engineering
Growing functional blood vessel networks is no easy task. Previously, other groups have made networks that span millimeters in size.
Next-gen batteries possible with new engineering approach
Dramatically longer-lasting, faster-charging and safer lithium metal batteries may be possible, according to Penn State research, recently published in Nature Energy.
What can snakes teach us about engineering friction?
If you want to know how to make a sneaker with better traction, just ask a snake.
Engineering a plastic-eating enzyme
Scientists have engineered an enzyme which can digest some of our most commonly polluting plastics, providing a potential solution to one of the world's biggest environmental problems.
A new way to do metabolic engineering
University of Illinois researchers have created a novel metabolic engineering method that combines transcriptional activation, transcriptional interference, and gene deletion, and executes them simultaneously, making the process faster and easier.
More Engineering News and Engineering Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.